Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146,467,184
-
Number of holders
-
410
-
Total 13F shares, excl. options
-
89,322,328
-
Shares change
-
+280,231
-
Total reported value, excl. options
-
$7,564,180,997
-
Value change
-
+$29,233,715
-
Put/Call ratio
-
56%
-
Number of buys
-
201
-
Number of sells
-
-139
-
Price
-
$84.69
Significant Holders of RESMED INC - Common Stock (RMD) as of Q4 2017
452 filings reported holding RMD - RESMED INC - Common Stock as of Q4 2017.
RESMED INC - Common Stock (RMD) has 410 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 89,322,328 shares
of 146,467,184 outstanding shares and own 61% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (14,281,291 shares), Capital World Investors (12,186,700 shares), BlackRock Inc. (11,144,062 shares), FMR LLC (8,068,133 shares), STATE STREET CORP (5,850,761 shares), BAILLIE GIFFORD & CO (4,915,855 shares), GEODE CAPITAL MANAGEMENT, LLC (1,730,716 shares), Bank of New York Mellon Corp (1,707,866 shares), NORTHERN TRUST CORP (1,677,151 shares), and NORGES BANK (1,099,025 shares).
This table shows the top 410 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.